| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.18 | 0.03 |